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Evaluation of direct microplate nitrate reductase assay
as a rapid method for the detection of multiple and extensively 
tuberculosis drug resistance
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Núcleo de Pesquisa em Microbiologia Médica, Faculdade de Medicina,
Universidade Federal do Rio Grande, Rio Grande, Brasil
Introduction: Reports of Mycobacterium tuberculosis resistant to multiple drugs are increasing globally 
and laboratories are becoming increasingly aware of the need for drug susceptibility testing. In recent 
years, due to the long time required by conventional drug susceptibility testing, new approaches have 
been proposed for faster detection of drug resistance, such as the nitrate reductase assay, considered 
fast and inexpensive, making it a good diagnostic tool for low resource countries.
Objective: The present study proposed a fast direct colorimetric drug susceptibility testing method in a 
microplate format using solid medium.
Materials and methods: The diagnostic accuracy was evaluated by comparing the proportion method 
with the direct nitrate reductase assay in plates. Frozen sputum samples, known to be positive, 
were decontaminated and processed by Petroff method. The decontaminated suspension was used 
to perform direct nitrate reductase assay in 7H11 medium using 1 µg/ml rifampicin (RIF), 0.2 µg/ml 
isoniazid (INH), 2 µg/ml ofloxacin (OFX), 6 µg/ml kanamycin (KAN), 2 µg/ml amikacin (AMK) and 10 µg/
ml capreomycin (CAP). Eighty-four samples were tested and the results for 69% of them were available 
within 21 days.
Results: The sensitivity and specificity compared to the proportion method, was 98.5% and 100% for 
INH, 98.3% and 96.2% for RIF, 91.7% and 100% for KAN, 78.8% and 97.3% for OFX, 100% and 100% 
for AMK and CAP, respectively.
Conclusion: The results lead to the conclusion that direct nitrate reductase assay, in this new format, 
is an accurate, quick and inexpensive method to determine the susceptibility profile of M. tuberculosis 
and may become an alternative for countries with limited resources.
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nitrate reductase. 
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Evaluación de la prueba de la nitrato reductasa directa en microplaca para la detección rápida 
de tuberculosis multirresistente y extensamente resistente a fármacos
Introducción. Los informes sobre Mycobacterium tuberculosis resistente a múltiples fármacos están 
aumentando a nivel mundial y los laboratorios toman cada vez más conciencia sobre la necesidad de 
realizar pruebas de sensibilidad a fármacos. Debido al tiempo prolongado que se requiere para hacerlas, 
se han propuesto nuevos enfoques para la detección rápida de resistencia a los medicamentos, tales 
como la prueba de la nitrato reductasa.
Objetivo. En este estudio se propuso una prueba de sensibilidad a fármacos colorimétrica, rápida y 
directa, en un formato de microplacas utilizando medio sólido.
Materiales y métodos. La precisión del diagnóstico se evaluó mediante la comparación del método de 
las proporciones con la prueba de la nitrato reductasa directa en placas. Se descontaminaron muestras 
positivas congeladas de esputo y se procesaron mediante el método de Petroff. La suspensión ya 
descontaminada se utilizó para hacer la prueba de la nitrato reductasa directa en medio 7H11, utilizando 
1 µg/ml de rifampicina, 0,2 µg/ml de isoniacida, 2 µg/ml de ofloxacina, 6 µg/ml de de kanamicina, 2 µg/ 
ml de amicacina y 10 µg/ml de capreomicina. Se analizaron 84 muestras y los resultados del 69 % de 
ellas estuvieron disponibles en 21 días.
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Resultados. La sensibilidad y la especificidad de la prueba comparada con el método de las 
proporciones fueron de 98,5 y 100 % para la isoniacida, de 98,3 y 96,2 % para la rifampicina, de 91,7 
y 100 para la kanamicina, de 78,8 y 97,3 % para la ofloxacina y de 100 y 100 % para la amikacina y la 
capremicina, respectivamente. 
Conclusión. Este nuevo formato de la prueba de la nitrato reductasa directa es un método preciso, 
rápido y económico para determinar el perfil de sensibilidad de M. tuberculosis y puede convertirse en 
una alternativa para los países con recursos limitados.
Palabras clave: Mycobacterium tuberculosis, tuberculosis, esputo, antituberculosos, resistencia a 
medicamentos, nitrato-reductasa. 
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Tuberculosis remains a major public health problem 
worldwide, especially in developing countries. Such 
situation is worsened by the increasing incidence of 
multidrug resistant tuberculosis (MDR-TB), caused 
by strains resistant to at least isoniazid (INH) 
and rifampicin (RIF), and of extensively resistant 
tuberculosis (XDR-TB) caused by a MDR-TB strain 
also resistant to fluoroquinolone and to at least one 
of the following antimicrobial agents: kanamycin 
(KAN), amikacin (AMK) and/or capreomycin (CAP). 
Tuberculosis caused by resistant strain requires an 
expensive, longer and less effective treatment (1).
Drug resistance surveillance data indicate that in 
2013, approximately 480,000 people developed 
MDR-TB worldwide and approximately 210,000 
deaths. An estimated 3.5% of new cases and 20.5% 
of previously treated cases have MDR-TB. Despite 
progress in the detection of MDR/RR-TB cases, 
a major diagnostic gap remains: 55% of reported 
tuberculosis patients estimated to have MDR-TB 
were not detected in 2013 (2).
By the end of 2013, 100 countries and territories 
reported at least one case of XDR-TB while 
countries like Iran, India and Italy have reported 
cases of pan-drug resistant tuberculosis (PDR-TB). 
Of 269 XDR-TB patients reported in 40 countries in 
the 2011 cohort overall, only 284 (22%) completed 
their treatment successfully and 438 (35%) patients 
died (2-5).
In countries with limited resources, where tuber-
culosis is endemic and MDR-TB is a serious 
and growing public health problem, the drug 
susceptibility test is still based on conventional 
methods of culture in solid medium as Löwenstein-
Jensen and Middlebrook agar, which are laborious 
and time consuming, requiring at least 4 weeks of 
incubation after the primary isolation to consider a 
strain as susceptible or resistant (6).
The development of an alternative robust test, fast 
and inexpensive, that can be done directly from 
the sputum is extremely important and urgent 
for tuberculosis control programs and allows 
rapid detection of new resistant cases as well as 
monitoring tuberculosis patients with resistant 
strains (6).
One affordable option for rapid drug resistance 
detection is the nitrate reductase assay that uses 
colorimetric detection of nitrite as an indicator 
of growth. It requires no elaborate equipment, 
expensive substrates or reagents. Although nitrate 
reductase assay has been shown to be highly 
sensitive and specific in the detection of rifampicin 
and isoniazid resistance, additional studies are 
required to determine its performance in a target 
population, i.e., a population in which multidrug-
resistant tuberculosis is suspected (7).
The aim of this study was to evaluate the perfor-
mance of nitrate reductase assay in plates in a 
direct manner, and to determine the susceptibility 
of M. tuberculosis strains directly from sputum 
samples using INH, RIF, ofloxacin (OFX), KAN, 
CAP and AMK.
Materials and methods
Proportion method
The proportion method is still regarded as the gold 
standard for anti-TB drugs and was performed 
indirectly, with the isolated strains from sputum 
samples at the time of their arrival at the laboratory. 
The technique was performed in Löwenstein-
Jensen media, following the simplified protocol 
described by Canetti, Rist and Grosset (8) in 15 
ml Falcon tubes, with or without antibiotics. The 
antibiotics concentrations used were: 40 µg/ml RIF 
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(Sigma-Aldrich, Germany, 7382), 0.2 µg/ml INH 
(Sigma-Aldrich, Germany, 3377), 2 µg/ml OFX 
(Sigma-Aldrich, Germany, 8757), 20 µg/ml KAN 
(Sigma-Aldrich, Germany, 4000), 40 µg/ml AMK 
(Sigma-Aldrich, Germany, 1774) and 20 µg/ml CAP 
(Sigma-Aldrich, Germany, 4142). 
For each strain, a bacterial suspension was made by 
transferring bacterial colonies to a tube containing 
glass beads and 2.5 ml of sterile distilled water. 
This suspension was equivalent to McFarland 
number 1 tube. Part of this suspension was diluted 
1:100, and 200 µl of this dilution were inoculated in 
Löwenstein-Jensen media without antibiotics while 
200 µl of undiluted suspension were inoculated 
into Löwenstein-Jensen media with antibiotics. The 
tubes were incubated at 37°C for 28 days when the 
first reading was taken. If there was not enough 
growth to allow results interpretation, a second 
reading was performed at 42 days of incubation.
The strain was considered resistant when the ratio 
between the growth in tubes containing antibiotic 
and the control tubes was higher than 1% with all 
antibiotics. The results obtained by the proportion 
method were used as gold standard to be com-
pared with the results of direct nitrate reductase 
assay in plates (9).
Natural samples
A total of 94 frozen sputum samples (-20°C) from 
different patients non-previously decontaminated 
and with known susceptibility profile (determined 
by the proportion method) were selected from the 
collection of the Laboratório de Micobactérias, 
Universidade Federal do Rio Grande, Brazil. Direct 
nitrate reductase assay in plates was performed on 
84 sputum samples, as 10 (10.6%) of them were 
contaminated. Among the chosen samples, we had 
46 MDR-TB isolates, 6 XDR-TB, 2 INH resistant plus 
one drug, 14 isoniazid-monoresistant, 3 rifampicin-
monoresistant and 13 pan-susceptible. The selec-
tion criterion was based on the susceptibility profile 
and provenience, since the target population was 
from low-income countries. In order to have a 
significant sampling, the samples were chosen 
mostly from Kinshasa, Democratic Republic of 
Congo, Africa, where the incidence of tuberculosis 
cases is 326/100,000 and 272 cases of MDR-TB 
were notified in 2013 (2).
The samples were decontaminated through the 
Petroff modified method (10). In short, a volume of 
approximately 2 ml of sputum was decontaminated 
with an equal volume of 4% NaOH solution. 
Tubes containing the samples were placed in a 
bacteriological incubator for 15 minutes at 36±1°C 
for sample fluidization. After this, the tube volume 
was completed with sterile distilled water and the 
neutralizing solution (1N HCl) was dripped until 
an amber coloration appeared. Then, the tubes 
were centrifuged for 15 minutes at 3000g, the 
supernatant discarded and the pellet re-suspended 
in 1 ml of sterile distilled water. The schematic plate 
design can be seen in figure 1.
Direct nitrate reductase assay in plates
The indirect method proposed by Ängeby, Klintz and 
Hoffner (7) was used as a model, with modifications 
in format, culture medium, antibiotics concentration 
and number of controls. A 24-well microplate was 
used with 2 ml of 7H11 (chosen for being a more 
enriched medium than Löwenstein-Jensen media, 
which can shorten the time for obtaining results), 
enriched with 10% of Middlebrook oleic acid 
Figure 1. Schematic plate design
R: Rifampicin; I: Isoniazid; O: Ofloxacin; K: Kanamicyn; A: Amikacyn; C: Capreomicyn; PNB: ρ-nitrobenzoic acid; 
GC: Growth control; SC: Sterility control. Antibiotics concentration given in µg/ml 
Sample 1
Sample 2
R-1.0
GC14d GC21d GC28d GC35d PNB SC
GC14d GC21d GC28d GC35d PNB SC
I-0.2 O-2.0 K-6.0 A-2.0 C-10.0
R-1.0 I-0.2 O-2.0 K-6.0 A-2.0 C-10.0
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albumin dextrose catalase enrichment, potassium 
nitrate (KNO3) in a concentration of 1 mg/ml with or 
without antibiotics incorporated into each well.
Antibiotics concentrations were: 1 µg/ml RIF 
(Sigma-Aldrich, Germany, 7382), 0.2 µg/ml INH 
(Sigma-Aldrich, Germany, 3377), 2 µg/ml OFX 
(Sigma-Aldrich, Germany, 8757), 6 µg/ml KAN 
(Sigma-Aldrich, Germany, 4000), 2 µg/ml AMK 
(Sigma-Aldrich, Germany, 1774), 10 µg/ml CAP 
(Sigma-Aldrich, Germany, 4142) and 25 µg/ml 
p-nitrobenzoic acid (PNB) (Acros Organics – 
A0260097). The PNB was included in this study 
to differentiate strains belonging to Mycobacterium 
tuberculosis complex from non-tuberculous myco-
bacterium, since the latter are the only ones that 
grow in the presence of this drug (11). To eliminate 
contamination, the cultures were observed every 2 
days to check for any possible growth. The control 
wells were stained to confirm the presence of acid-
fast growth.
After the sample decontamination and resus-
pension of the pellet, sterile distilled water was 
added to complete a volume of 3 ml. This was 
considered as the working solution. The working 
solution was inoculated into the test wells and 
a dilution of 1:10 was made. This last one was 
called the diluted solution and was inoculated into 
control wells.
For each sample, 200 µl of the working solution 
were inoculated in test wells containing 7H11, 
KNO3, antibiotics while 200 µl of the diluted solution 
were inoculated in control wells which contained 
only the culture medium and KNO3. The sterility 
control was done by the inoculation of 200 µl of 
water in a control well.
The plate was incubated at 37°C in aerobic 
atmosphere, inside a sealed plastic bag. After 
14 days, 0.5 ml of freshly mixed Griess reagent 
(1 part of 50% hydrochloric acid, 2 parts of 0.2% 
sulfanilamide and 2 parts of 0.1% n-1-naphthyl 
ethylene-ediamine) was added to control wells. 
If there was any color change (pale pink-strong 
pink), the test wells were also revealed. If there 
was no color change in the control well, the plate 
was incubated again and the procedure was 
repeated at 21, 28 or 35 days. A sample was 
considered to be resistant to a certain drug if 
there was any color change.
Pan-susceptible M. tuberculosis H37Rv reference 
strain and a known MDR M. tuberculosis isolate 
were used as quality controls.
Ethical aspects
This study was based on ethical principles and was 
approved by the Research Ethics Committee in 
the Area of Health of the Federal University of Rio 
Grande, Protocol 23116.003686/2012-31.
Results
The results of 18 (21.4%), 58 (69.05%), 6 (7.14%) 
and 2 (2.4%) samples were obtained after 14, 
21, 28 and 35, respectively, and then compared 
with those produced by proportion method. Direct 
nitrate reductase assay was easily read, one 
example of sensitive and resistant strains can be 
seen in figure 2.
Regarding the indirect proportion method, we 
obtained results of 22 (26.2%) of the samples in 28 
days and of 62 of the samples (73.8%) in 42 days, 
adding to that time 21 days on average for growing 
strains, totaling 49 or 63 days to obtain the results 
of drug susceptibility testing (figure 3).
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Figure 2. Example of direct nitrate reductase assay in plates. 
Sample A was totally resistant and sample B was totally 
sensitive.
Figure 3. Cumulative percentage of positive results through 
direct nitrate reductase assay in plates and proportion method 
DNRA: direct nitrate reductase assay; PM: proportion method
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The comparison of direct nitrate reductase assay 
and proportion method (table 1) shows an agree-
ment of 97.4% (491 of 504 individual sensitivity 
tests), 1.19% of inconclusive samples (6 of 504 
tests - corresponding to 3 different samples) and 
0.79% of discordant samples (4 of 504 tests). 
Considering the discordant samples, the sensitivity 
and specificity were 98.5% and 100% for INH, 
98.3% and 100% for RIF, 91.7% and 100% for 
KAN, 81.8% and 100% for OFX, 100% and 100% 
for AMK and 100% and 100% for CAP. An excellent 
agreement was obtained between direct nitrate 
reductase assay and proportion method, with a 
kappa value of 0.96 for INH, 0.97 for RIF, 0.95 for 
KAN, 0.89 for OFX and 1.0 for AMK and CAP.
The positive predictive values were 100% for all 
drugs. The negative values were 93.3%, 95.8%, 
97.2%, 98.6%, 100% and 100% for INH, RIF, KAN, 
OFX, AMK and CAP, respectively.
The accuracy of direct nitrate reductase assay in 
plates in relation to the gold standard was 98.8% 
for INH, 98.8% for RIF and KAN, 97.5% for OFX 
and 100% for AMK and CAP.
Discussion
In low-income countries, particularly those where 
the burden of tuberculosis caused by resistant 
strains is high, there is an urgent need for drug 
susceptibility testing for first and second line drugs 
used to treat tuberculosis. These methods should 
be easy to use, give rapid and accurate results and 
have low cost (12).
Although direct nitrate reductase assay in tube is 
a well-known method, the microplate format is a 
more compact device and permits a rapid detection 
of MDR-TB and XDR-TB strains in just one platform 
(13,14). 
Furthermore, direct nitrate reductase assay 
reduced diagnosis time, low cost and straightfor-
ward implementation (6,15) without any need for 
special equipment or expensive reagents and, 
finally, greater biosafety, since there is no need for 
carrying out serial dilutions, as in the proportion 
method (16).
In this study, approximately 69% of the results of 
direct nitrate reductase assay were obtained after 
21 days of incubation. This represents a significant 
reduction of time, since the results of the proportion 
method performed indirectly are obtained 50 days 
after their arrival at the laboratory on average, 
since 21-28 days are required for strain isolation 
and 28-42 days for the drug susceptibility testing. 
The nitrate reductase assay is based on the 
detection of nitrate reduction as an indicator of 
growth, and the results, therefore, are obtained 
before any macroscopic growth can be visually 
detected. Despite this reduction in time, there is 
a need for further comparative studies with direct 
drug susceptibility testing.
Our results confirm previous findings with direct 
nitrate reductase assay carried out with INH, RIF, 
STR and ethambutol (EMB) (1,6,12,15-24). The 
sensitivity and specificity varied between 87-100%, 
87.5-100%, 66.6-100%, 55-100%, respectively.
In a multicentric study carried out by Martin, et al., 
the accuracy for RIF ranged between 93.7% and 
100%, for INH, between 88.2% and 100%, for 
OFX, between 94.6% and 100%, and for KAN the 
Table 1. Sensitivity and specificity of direct DST in 84 sputum samples through direct nitrate reductase assay in plates and 
proportion method 
Antibiotics Proportion 
method
DNRA in plates Kappa
value
PPV
(%)
NPV
(%)
Resistant (n) Susceptible (n) Sensitivity (%) Specificity (%)
INH
RIF
OFX
KAN
AMK
CAP
Resistant
Susceptible
Resistant
Susceptible
Resistant
Susceptible
Resistant
Susceptible
Resistant
Susceptible
Resistant
Susceptible
66
  0
57
  0
  9
  0
11
  0
  4
  0
  7
  0
  1
14
  1
23
  2
70
  1
69
  0
78
  0
74
98.5
98.3
81.8
91.7
100
100
100
100
100
100
100
100
0.96
0.97
0.89
0.95
1.0
1.0
100
100
100
100
100
100
93.3
95.8
97.2
98.6
100
100
DNRA: direct nitrate reductase assay; PPV: positive predictive value; NPV: negative predictive value
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accuracy was 100%. They also had the majority of 
positive results at 21 days (25). Imperiale, et al., 
found that the direct nitrate reductase assay had 
a turn-around time of 16.9 days to obtain results 
while that of the indirect MGIT 960 system was 29 
days (26). 
In our study, there was a high agreement between 
the direct nitrate reductase assay and the proportion 
method for five of the six antibiotics tested. The high 
performance for INH and RIF must be highlighted, 
since these are the most commonly used drugs in 
tuberculosis treatment (16). 
In 2005, Martin, et al., reported the evaluation of 
the nitrate reductase assay for the detection of OFX 
resistance and found complete concordance with 
the proportion method. Rosales, et al., evaluated 
the nitrate reductase assay for the rapid detection 
of resistance to OFX and KAN in Honduras. They 
found good specicity for both drugs, but lower 
sensitivity for detecting resistance to KAN (27). 
Visalakshi, et al., evaluated the nitrate reductase 
assay for rapid detection of resistance to KAN, 
EMB, OFX, cycloserine and para aminosalicylic 
acid. They obtained a sensitivity ranging between 
86.4% and 100%, while specificity ranged between 
98.4% and 100% (28).
For OFX, the result of a sensitivity of 81.8% was 
not as good. However, the specificity remained 
excellent (100%). The accuracy of the method for 
this particular drug was 97.5%. A small number 
of discordant samples hampered the analysis of 
the test for this drug, since the number of OFX 
resistant samples tested was small; it is suggested 
that further studies are needed to correctly classify 
a case as MDR-TB or XDR-TB using this new 
method. Martin, et al., also found lower sensitivity 
for OFX due to the very low number of strains 
resistant to this drug (25). 
Unlike our results, Kurup and George found a higher 
sensitivity for RIF than for INH, as well as greater 
negative agreement indices than positive ones (28). 
Although direct nitrate reductase assay in micro-
plates has significant advantages, it is important to 
take into account limitations such as the possibility 
that resistant strains may have lower metabolic 
activity, a fact that can affect the expression levels 
of enzymes responsible for nitrate reduction that 
cannot be detected by nitrate reductase assay 
(18). Another considerations refers to a possible 
interaction between the antibiotics and KNO3, 
which is still unknown and should be considered in 
future assessments (14).
The improvement in the diagnosis of susceptible 
and resistant tuberculosis strains through molecular 
methods is significant; however, these methods 
detect well-known resistance molecular bases, 
mainly to RIF and INH. The molecular bases of 
resistance to second-line drugs are less known, 
so the capacity to detect resistance to these drugs 
have a low level of accuracy through molecular 
methods while phenotypic methods such as the 
direct nitrate reductase assay detect resistance 
independently of its molecular bases and have a 
higher sinsitivity for the detection of tuberculosis 
resistant strains.
In conclusion, our results suggest that the direct 
nitrate reductase assay can be a useful tool for 
multidrug-resistant tuberculosis detection since it is 
fast, low-cost and accurate, and it determines both 
first and second-line drugs profile of susceptibility 
directly from the clinical sample.
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